Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.

  title={Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.},
  author={Luke R Frederick and Omer Onur Cakir and Hans C Arora and Brian T. Helfand and Kevin T McVary},
  journal={The journal of sexual medicine},
  volume={11 10},
INTRODUCTION Prior research conducted on treatment of erectile dysfunction (ED) has been derived from surveys involving relatively small populations of men. There are needs for large population-based studies in this area. Our study addresses that need. AIM The aim of this study was to characterize ED treatment among a large population of men. METHODS Patients ≥30 years in commercial insurance dataset with diagnosis code for ED during 12-month period ending June 2011 were identified. Men… 
Medical Treatment of Erectile Dysfunction: Too Many Medical Prescriptions?
Treatment of ED should carefully follow internationally based clinical guidelines to avoid inappropriate drug prescriptions, which may eventually expose treated patients to drug-related side effects, and a careful assessment of the so-called modifiable and reversible ED risk factors along with a patient-tailored screening for potential contraindications to the treatment itself should be performed in every case.
Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction
The pharmacological treatment of erectile dysfunction was in accordance with the recommendations of clinical practice guidelines, but the high proportion of potentially inappropriate prescriptions makes it necessary to promote educational and pharmacovigilance strategies that improve the prescription habits of physicians involved in caring for this group of patients.
Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study
Erectile dysfunction may have important effects on emotional and social well-being, and may affect outcome in male opioid users on ORT through a simple and quick self-assessment tool.
Editorial Comment: Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care
  • V. Javaroni
  • Medicine
    International braz j urol : official journal of the Brazilian Society of Urology
  • 2020
The need for continuous medical education on general practitioner (GP) level regarding sexual dysfunction in Portugal and the importance and role of the general practitioner in the management of erectile dysfunction (ED) is highlighted.
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden
Pharmacy dispensing of ED medication seem linked to the individuals socioeconomic position, age and marital status suggesting sociodemographic disparities in the pharmacy dispensing targeting sexual function, but the low DA of the associations shows the limited capacity of these factors to predict ED medication use at the individual level.
Prevalence of use of erectile dysfunction medication by Dutch military personnel between 2003 and 2012
A strong increase between 2003 and 2012 in a number of ED medication users in male Dutch military personnel is shown, which is associated with increasing age, exposure to traumatic events and physical injuries in military veterans.
Tadalafil therapy for erectile dysfunction following prostatectomy
Tadalafil is a long-acting, potent PDE-5 inhibitor for erectile dysfunction, with demonstrated effect in animal studies at preserving penile smooth muscle content and prevention of fibrosis of cavernosal tissue.
Relationship between age and erectile dysfunction diagnosis or treatment using real‐world observational data in the USA
With self‐reporting of erectile dysfunction (ED) in population‐based surveys, men with ED may not represent men who are bothered sufficiently to seek an ED diagnosis and treatment. We used real‐world


Under-reporting of erectile dysfunction among men with unrelated urologic conditions
By far, the most common reason for under-reporting of ED was patient embarrassment, while urologists are able to elicit information regarding erectile function on specific questioning, patients appear comfortable and willing to discuss their potency with primary-care physicians.
Prostaglandin E1 for treatment of erectile dysfunction.
The use of PGE1 in ED could have been better interpreted if its effectiveness were compared by aetiology and with different forms of administrations, a longer follow-up were considered and more emphasis given to patient/partner relationships and quality of life.
Erectile dysfunction in general medicine practice: prevalence and clinical correlates
Hypertension, ischaemic heart disease, peripheral vascular disease and diabetes mellitus were frequently associated with ED, and 40% of diabetic men aged 60-y or older had ED all the time.
Which patients with sexual dysfunction are suitable for testosterone replacement therapy?
The main purpose of this review is to discuss the role of testosterone (T) in men’s sexual function, including epidemiology, pathophysiology, diagnostic procedures, and treatment efficacy in patients affected by erectile dysfunction (ED).
Testosterone therapy in erectile dysfunction and hypogonadism.
  • R. Shabsigh
  • Medicine, Biology
    The journal of sexual medicine
  • 2005
It is important to screen all men with ED for hypogonadism, especially those with a history of inadequate response to prior PDE5 inhibitors, and the combination of testosterone plus PDE4 inhibitors may be considered for the treatment of ED in men with low to low-normal testosterone levels.
[Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
  • R. Rosen, J. Altwein, F. Giuliano
  • Medicine
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
  • 2004
The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience
The quantity of research and quality of scholarship on the SHIM provide testimony to its positive impact on understanding and improving male sexual function and it is likely to remain influential in coming years.